Biomarker for Cognitive Fatigue Using Functional Imaging in Multiple Sclerosis
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this research study is to investigate the effectiveness of Tysabri on cognitive fatigue in persons with Relapsing-Remitting Multiple Sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of problem solving.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 64
Healthy Volunteers: t
View:
• Age between 18-64
• Diagnosed with Relapsing-Remitting Multiple Sclerosis or a healthy volunteer
• If diagnosed with MS: has been newly prescribed Tysabri, but has not yet started taking the medication
• Can read and speak English fluently
Locations
United States
New Jersey
Kessler Foundation
RECRUITING
West Orange
Contact Information
Primary
Nancy Moore, M.A.
nbmoore@kesslerfoundation.org
19733248450
Backup
Angela Smith, M.A.
asmith@kesslerfoundation.org
19733248448
Time Frame
Start Date: 2021-03-19
Estimated Completion Date: 2024-12
Participants
Target number of participants: 25
Treatments
Group 1: Multiple Sclerosis
Individuals with RRMS who are going to be starting Tysabri as determined by Neurologist as part of clinical care.~Intervention: Drug: Tysabri
Group 2: Healthy Controls
Healthy individuals who are age, gender and education matched to the MS group.
Related Therapeutic Areas
Sponsors
Collaborators: St. Barnabas Medical Center
Leads: Kessler Foundation